The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
Self-citationIL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
Innate immunity to influenza virus infection
Iwasaki, A., & Pillai, P. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3665 · Cited by 1,068
Role of deficient type III interferon-λ production in asthma exacerbations
Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A. B., Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1462 · Cited by 1,006
Self-citationProkunina-Olsson, L., Muchmore, B., Tang, W., Pfeiffer, R. M., Park, H., Dickensheets, H., Hergott, D., Porter-Gill, P., Mumy, A., Kohaar, I., et al. (2013) · Nature Genetics · doi:10.1038/ng.2521 · Cited by 928
Influenza A viruses: new research developments
Medina, R. A., & García-Sastre, A. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2613 · Cited by 677
Abram, C. L., Roberge, G. L., Hu, Y., & Lowell, C. A. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.05.009 · Cited by 506
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
Lazear, H. M., Nice, T. J., & Diamond, M. S. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.001 · Cited by 480
Mordstein, M., Neugebauer, E., Ditt, V., Jessen, B., Rieger, T., Falcone, V., Sorgeloos, F., Ehl, S., Mayer, D., Kochs, G., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00272-10 · Cited by 443
JunB Deficiency Leads to a Myeloproliferative Disorder Arising from Hematopoietic Stem Cells
Passegué, E., Wagner, E. F., & Weissman, I. L. (2004) · Cell · doi:10.1016/j.cell.2004.10.010 · Cited by 440
An Important Role for Type III Interferon (IFN-λ/IL-28) in TLR-Induced Antiviral Activity
Ank, N., Iversen, M. B., Bartholdy, C., Staeheli, P., Hartmann, R., Jensen, U. B., Dagnaes-Hansen, F., Thomsen, A. R., Chen, Z., Haugen, H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2474 · Cited by 419
IFN-λ determines the intestinal epithelial antiviral host defense
Pott, J., Mahlakõiv, T., Mordstein, M., Duerr, C. U., Michiels, T., Stockinger, S., Staeheli, P., & Hornef, M. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100552108 · Cited by 416
Brandes, M., Klauschen, F., Kuchen, S., & Germain, R. N. (2013) · Cell · doi:10.1016/j.cell.2013.06.013 · Cited by 381
Pathogenic potential of interferon αβ in acute influenza infection
Davidson, S., Crotta, S., McCabe, T. M., & Wack, A. (2014) · Nature Communications · doi:10.1038/ncomms4864 · Cited by 369
Guarding the frontiers: the biology of type III interferons
Wack, A., Terczyńska-Dyla, E., & Hartmann, R. (2015) · Nature Immunology · doi:10.1038/ni.3212 · Cited by 364
Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity
Nice, T. J., Baldridge, M. T., McCune, B. T., Norman, J. M., Lazear, H. M., Artyomov, M., Diamond, M. S., & Virgin, H. W. (2015) · Science · doi:10.1126/science.1258100 · Cited by 345
Mordstein, M., Kochs, G., Dumoutier, L., Renauld, J.-C., Paludan, S. R., Klucher, K., & Staeheli, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000151 · Cited by 325
Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm
Okubo, T., & Hogan, B. L. (2004) · Journal of Biology · doi:10.1186/jbiol3 · Cited by 288
Hernández, P. P., Mahlakõiv, T., Yang, I., Schwierzeck, V., Nguyen, N., Guendel, F., Gronke, K., Ryffel, B., Hölscher, C., Dumoutier, L., et al. (2015) · Nature Immunology · doi:10.1038/ni.3180 · Cited by 287
Crotta, S., Davidson, S., Mahlakoiv, T., Desmet, C. J., Buckwalter, M. R., Albert, M. L., Staeheli, P., & Wack, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003773 · Cited by 269
Muir, A. J., Shiffman, M. L., Zaman, A., Yoffe, B., de la Torre, A., Flamm, S., Gordon, S. C., Marotta, P., Vierling, J. M., Carlos Lopez-Talavera, J., et al. (2010) · Hepatology · doi:10.1002/hep.23743 · Cited by 249
Davidson, S., McCabe, T. M., Crotta, S., Gad, H. H., Hessel, E. M., Beinke, S., Hartmann, R., & Wack, A. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606413 · Cited by 240
Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier
Lazear, H. M., Daniels, B. P., Pinto, A. K., Huang, A. C., Vick, S. C., Doyle, S. E., Gale, M., Klein, R. S., & Diamond, M. S. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4304 · Cited by 234
Self-citationMennechet, F. J. D., & Uzé, G. (2006) · Blood · doi:10.1182/blood-2005-10-4129 · Cited by 220
Interferon induction and function at the mucosal surface
Durbin, R. K., Kotenko, S. V., & Durbin, J. E. (2013) · Immunological Reviews · doi:10.1111/imr.12101 · Cited by 220
Self-citationMahlakõiv, T., Hernandez, P., Gronke, K., Diefenbach, A., & Staeheli, P. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004782 · Cited by 216
IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production
Blazek, K., Eames, H. L., Weiss, M., Byrne, A. J., Perocheau, D., Pease, J. E., Doyle, S., McCann, F., Williams, R. O., & Udalova, I. A. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140995 · Cited by 216
Self-citationNeutrophils in viral infections: Current concepts and caveats
Galani, I. E., & Andreakos, E. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4vmr1114-555r · Cited by 214
Self-citationKoltsida, O., Hausding, M., Stavropoulos, A., Koch, S., Tzelepis, G., Übel, C., Kotenko, S. V., Sideras, P., Lehr, H. A., Tepe, M., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100142 · Cited by 207
Self-citationBolen, C. R., Ding, S., Robek, M. D., & Kleinstein, S. H. (2014) · Hepatology · doi:10.1002/hep.26657 · Cited by 193
Lin, J.-D., Feng, N., Sen, A., Balan, M., Tseng, H.-C., McElrath, C., Smirnov, S. V., Peng, J., Yasukawa, L. L., Durbin, R. K., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005600 · Cited by 171
Self-citationMendoza, J. L., Schneider, W. M., Hoffmann, H.-H., Vercauteren, K., Jude, K. M., Xiong, A., Moraga, I., Horton, T. M., Glenn, J. S., de Jong, Y. P., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.017 · Cited by 121
Dai, J., Megjugorac, N. J., Gallagher, G. E., Yu, R. Y.-L., & Gallagher, G. E. (2009) · Blood · doi:10.1182/blood-2008-09-179507 · Cited by 116
Kohli, A., Zhang, X., Yang, J., Russell, R. S., Donnelly, R. P., Sheikh, F. G., Sherman, A. C., Young, H. A., Imamichi, T., Lempicki, R. A., et al. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2012.01610.x · Cited by 53
Type III interferons (IFNs): Emerging Master Regulators of Immunity
Galani, I. E., Koltsida, O., & Andreakos, E. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-15774-0_1 · Cited by 35
Self-citationSmee, D. F., von Itzstein, M., Bhatt, B., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01664-12 · Cited by 27
Cited by
Sheahan, T. P., Sims, A. C., Leist, S. R., Schäfer, A., Won, J., Brown, A. J., Montgomery, S. A., Hogg, A., Babusis, D., Clarke, M. O., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13940-6 · Cited by 1,738
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
Park, A., & Iwasaki, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.008 · Cited by 909
Decoding type I and III interferon signalling during viral infection
Mesev, E. V., LeDesma, R. A., & Ploss, A. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0421-x · Cited by 538
Galani, I.-E., Rovina, N., Lampropoulou, V., Triantafyllia, V., Manioudaki, M., Pavlos, E., Koukaki, E., Fragkou, P. C., Panou, V., Rapti, V., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00840-x · Cited by 503
Self-citation
Metadata
- Authors
- Galani, I. E., Triantafyllia, V., Eleminiadou, E.-E., Koltsida, O., Stavropoulos, A., Manioudaki, M., Thanos, D., Doyle, S. E., Kotenko, S. V., Thanopoulou, K., & Andreakos, E.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 46
- Issue
- 5
- Pages
- 875-890.e6
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2616524644
- Cited by
- 477
- References
- 37
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.